Skin aging involves complex molecular changes that current strategies struggle to reverse. Here, we developed a machine learning approach using Support Vector Regression to predict biological skin age from proteomic profiles, enabling objective assessment of anti-aging formulations. In this exploratory, proof-of-concept, prospective observational study, we set out to characterize treatment-induced proteomic changes in human skin as the pre-specified primary outcome. Women (ages 20–80) received 30-day topical quinoa bioester application on one forearm, with the contralateral forearm receiving vehicle. Mass spectrometry revealed significant upregulation of barrier function proteins (desmoglein-1, filaggrin), antioxidant enzymes (SOD1, glutaredoxin-1), and protease inhibitors. Our Support Vector Regression (SVR) model, trained on pre-treatment proteomes, predicted lower proteomic ages for quinoa bioester-treated skin compared to vehicle-treated skin, with observed median differences of 11 and 16 years for participants under and over 50, respectively (p < 0.01 for participants ≥50 years). While these values do not necessarily correspond to biological years, these findings demonstrate that topical bioactives can induce detectable shifts in skin proteomic profiles. These results establish a quantitative framework for evaluating skin rejuvenation strategies and suggest quinoa bioester as a promising anti-aging cosmeceutical.
The increasing prohibition of animal testing for cosmetic products has driven the development of alternative approaches to ensure consumer safety. Skin sensitization is one of the most critical toxicological endpoints to evaluate, requiring rigorous assessment to ensure the safety of cosmetic ingredients. This study proposes an Integrated Testing Strategy (ITS) that combines in chemico (Direct Peptide Reactivity Assay—DPRA) and in silico approaches (a six-platform computational panel) to evaluate the sensitization potential of substances. Initially, the in chemico methodology was validated through a partial proficiency demonstration to ensure experimental reliability. Subsequently, this ITS was applied to the Baccharis trimera extract and its major marker, 3-Caffeoylquinic acid (chlorogenic acid/3-CQA). Our results demonstrate that the DPRA alone is insufficient to classify the sensitization potential of complex mixtures, as recommended by OECD guidelines. The integration of in silico data proved essential to interpret the reactivity of the botanical matrix, revealing that the sensitization potential observed in the extract does not stem solely from 3-CQA, but likely results from the synergistic contribution of more lipophilic caffeoylquinic acid isomers. This approach demonstrates that integrating experimental and computational methods is fundamental for a robust safety assessment, offering an efficient, animal-free strategy for the early screening of cosmetic ingredients and for refining the interpretation of toxicological data in complex chemical environments.